Eagle Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US2697961082

Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di ProQuest Associates IV LLC. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan ProQuest Associates IV LLC telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
US:URGN / UroGen Pharma Ltd. 10% Owner 1.242.031
US:EGRX / Eagle Pharmaceuticals, Inc. 10% Owner 149.107
US:AGRX / Agile Therapeutics, Inc. 10% Owner 5.062.363
US:IMDZ / Immune Design Corp. 10% Owner 1.983.858
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh ProQuest Associates IV LLC. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Pembelian Insider EGRX / Eagle Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada EGRX / Eagle Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Pengembalian Maksimal (%)
2014-02-18 EGRX ProQuest Associates IV LLC 333.333 15,0000 333.333 15,0000 4.999.995 365 36.7500 7.249.993 145,00

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Penjualan Insider EGRX / Eagle Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di EGRX / Eagle Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Minimal
Harga di
Minimal
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2017-04-25 EGRX ProQuest Investments IV, L.P. 51.219 88,3400 51.219 88,3400 4.524.686 104 46.6200 -2.136.856 -47,23
2017-04-25 EGRX ProQuest Investments IV, L.P. 2.961 89,0900 2.961 89,0900 263.795
2017-04-03 EGRX ProQuest Investments IV, L.P. 61.420 83,1300 61.420 83,1300 5.105.845
2017-03-31 EGRX ProQuest Investments IV, L.P. 23.689 83,0200 23.689 83,0200 1.966.661
2017-03-30 EGRX ProQuest Investments IV, L.P. 6.223 83,0000 6.223 83,0000 516.509
2017-03-29 EGRX ProQuest Investments IV, L.P. 58.755 83,0100 58.755 83,0100 4.877.253
2017-03-29 EGRX ProQuest Investments IV, L.P. 500 83,0100 500 83,0100 41.505
2017-03-29 EGRX ProQuest Investments IV, L.P. 1.600 83,0100 1.600 83,0100 132.816
2017-03-28 EGRX ProQuest Investments IV, L.P. 6.182 83,0200 6.182 83,0200 513.230
2017-03-27 EGRX ProQuest Investments IV, L.P. 37.731 83,0000 37.731 83,0000 3.131.673
2017-03-27 EGRX ProQuest Investments IV, L.P. 400 83,0000 400 83,0000 33.200
2017-03-27 EGRX ProQuest Investments IV, L.P. 1.300 83,0000 1.300 83,0000 107.900
2017-03-23 EGRX ProQuest Investments IV, L.P. 700 83,0100 700 83,0100 58.107
2017-03-21 EGRX ProQuest Investments IV, L.P. 500 83,1000 500 83,1000 41.550
2017-03-20 EGRX ProQuest Investments IV, L.P. 51.883 82,1000 51.883 82,1000 4.259.594
2017-03-17 EGRX ProQuest Investments IV, L.P. 38.997 82,0100 38.997 82,0100 3.198.144
2017-03-16 EGRX ProQuest Investments IV, L.P. 9.120 82,0800 9.120 82,0800 748.570
2017-01-04 EGRX ProQuest Investments IV, L.P. 65.114 85,1600 65.114 85,1600 5.545.108
2016-11-11 EGRX ProQuest Investments IV, L.P. 15.551 85,0000 15.551 85,0000 1.321.835
2016-11-10 EGRX ProQuest Investments IV, L.P. 15.368 85,1000 15.368 85,1000 1.307.817
2016-11-10 EGRX ProQuest Investments IV, L.P. 167 86,0000 167 86,0000 14.362
2016-11-10 EGRX ProQuest Investments IV, L.P. 100 86,0600 100 86,0600 8.606
2016-11-10 EGRX ProQuest Investments IV, L.P. 1.700 87,0500 1.700 87,0500 147.985
2016-11-10 EGRX ProQuest Investments IV, L.P. 300 85,0000 300 85,0000 25.500
2016-11-10 EGRX ProQuest Investments IV, L.P. 1.300 85,0000 1.300 85,0000 110.500
2016-11-09 EGRX ProQuest Investments IV, L.P. 1.380 75,7000 1.380 75,7000 104.466
2016-11-09 EGRX ProQuest Investments IV, L.P. 11.690 76,4900 11.690 76,4900 894.168
2016-11-09 EGRX ProQuest Investments IV, L.P. 9.030 77,1300 9.030 77,1300 696.484
2016-11-09 EGRX ProQuest Investments IV, L.P. 4.200 78,2300 4.200 78,2300 328.566
2016-11-09 EGRX ProQuest Investments IV, L.P. 19.581 79,2400 19.581 79,2400 1.551.598
2016-11-09 EGRX ProQuest Investments IV, L.P. 102.919 80,0900 102.919 80,0900 8.242.783
2016-11-07 EGRX ProQuest Investments IV, L.P. 5.030 75,3900 5.030 75,3900 379.212
2016-11-04 EGRX ProQuest Investments IV, L.P. 46.170 75,0000 46.170 75,0000 3.462.750
2016-11-02 EGRX ProQuest Investments IV, L.P. 146.371 70,0000 146.371 70,0000 10.245.970
2016-11-02 EGRX ProQuest Investments IV, L.P. 50.329 70,4100 50.329 70,4100 3.543.665
2016-11-02 EGRX ProQuest Investments IV, L.P. 800 70,0000 800 70,0000 56.000
2016-11-02 EGRX ProQuest Investments IV, L.P. 2.100 70,0000 2.100 70,0000 147.000
2016-09-30 EGRX ProQuest Investments IV, L.P. 22.100 70,0600 22.100 70,0600 1.548.326
2016-09-29 EGRX ProQuest Investments IV, L.P. 77.900 70,0400 77.900 70,0400 5.456.116
2016-09-21 EGRX ProQuest Investments IV, L.P. 97.149 66,1500 97.149 66,1500 6.426.406
2016-09-21 EGRX ProQuest Investments IV, L.P. 1.798 67,2400 1.798 67,2400 120.898
2016-09-21 EGRX ProQuest Investments IV, L.P. 194 66,1700 194 66,1700 12.837
2016-09-21 EGRX ProQuest Investments IV, L.P. 654 66,1700 654 66,1700 43.275
2016-09-08 EGRX ProQuest Investments IV, L.P. 33.796 62,3300 33.796 62,3300 2.106.505
2016-09-08 EGRX ProQuest Investments IV, L.P. 66 62,3300 66 62,3300 4.114
2016-09-08 EGRX ProQuest Investments IV, L.P. 224 62,3300 224 62,3300 13.962
2016-09-07 EGRX ProQuest Investments IV, L.P. 11.345 62,2600 11.345 62,2600 706.340
2016-09-07 EGRX ProQuest Investments IV, L.P. 22 62,2600 22 62,2600 1.370
2016-09-07 EGRX ProQuest Investments IV, L.P. 75 62,2600 75 62,2600 4.670
2016-09-06 EGRX ProQuest Investments IV, L.P. 12.958 62,4500 12.958 62,4500 809.227
2016-09-06 EGRX ProQuest Investments IV, L.P. 12.224 63,2500 12.224 63,2500 773.168
2016-09-06 EGRX ProQuest Investments IV, L.P. 49 62,8300 49 62,8300 3.079
2016-09-06 EGRX ProQuest Investments IV, L.P. 166 62,8300 166 62,8300 10.430
2016-08-24 EGRX ProQuest Investments IV, L.P. 11.506 62,7800 11.506 62,7800 722.347
2016-08-24 EGRX ProQuest Investments IV, L.P. 23 62,7800 23 62,7800 1.444
2016-08-24 EGRX ProQuest Investments IV, L.P. 76 62,7800 76 62,7800 4.771
2016-08-23 EGRX ProQuest Investments IV, L.P. 17.118 63,1400 17.118 63,1400 1.080.831
2016-08-23 EGRX ProQuest Investments IV, L.P. 34 63,1200 34 63,1200 2.146
2016-08-23 EGRX ProQuest Investments IV, L.P. 113 63,1200 113 63,1200 7.133
2016-08-17 EGRX ProQuest Investments IV, L.P. 4.723 60,8500 4.723 60,8500 287.395
2016-08-17 EGRX ProQuest Investments IV, L.P. 9.848 61,1900 9.848 61,1900 602.599
2016-08-17 EGRX ProQuest Investments IV, L.P. 29 61,0000 29 61,0000 1.769
2016-08-17 EGRX ProQuest Investments IV, L.P. 96 61,0000 96 61,0000 5.856
2016-08-16 EGRX ProQuest Investments IV, L.P. 16.270 60,6600 16.270 60,6600 986.938
2016-08-16 EGRX ProQuest Investments IV, L.P. 11.770 61,6500 11.770 61,6500 725.620
2016-08-16 EGRX ProQuest Investments IV, L.P. 31.599 62,2100 31.599 62,2100 1.965.774
2016-08-16 EGRX ProQuest Investments IV, L.P. 117 60,7800 117 60,7800 7.111
2016-08-16 EGRX ProQuest Investments IV, L.P. 394 60,7800 394 60,7800 23.947
2016-08-15 EGRX ProQuest Investments IV, L.P. 16.667 60,5100 16.667 60,5100 1.008.520
2016-08-15 EGRX ProQuest Investments IV, L.P. 8.070 61,3100 8.070 61,3100 494.772
2016-08-15 EGRX ProQuest Investments IV, L.P. 49 60,7000 49 60,7000 2.974
2016-08-15 EGRX ProQuest Investments IV, L.P. 163 60,7000 163 60,7000 9.894
2016-05-13 EGRX ProQuest Management LLC 13.980 40,9200 13.980 40,9200 572.062
2016-05-12 EGRX ProQuest Management LLC 4.000 40,0000 4.000 40,0000 160.000

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Pembelian Insider URGN / UroGen Pharma Ltd. - Analisis Keuntungan Jangka Pendek

Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada EGRX / Eagle Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Pengembalian Maksimal (%)
Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

URGN / UroGen Pharma Ltd. Insider Trades
Penjualan Insider URGN / UroGen Pharma Ltd. - Analisis Kerugian Jangka Pendek

Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di EGRX / Eagle Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Minimal
Harga di
Minimal
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2017-11-28 URGN ProQuest Investments IV, L.P. 177.807 40,5100 177.807 40,5100 7.202.962 15 36.8000 -659.663 -9,16
2017-11-27 URGN ProQuest Investments IV, L.P. 31.491 41,1200 31.491 41,1200 1.294.910

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

URGN / UroGen Pharma Ltd. Insider Trades
Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh ProQuest Associates IV LLC sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2017-11-29 2017-11-28 4 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
S - Sale -177.807 1.242.031 -12,52 40,51 -7.202.962 50.314.676
2017-11-29 2017-11-27 4 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
S - Sale -31.491 1.419.838 -2,17 41,12 -1.294.910 58.383.739
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other 149.107 149.107
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other 149.107 162.661 1.100,10
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other -3.584.087 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.360 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -3.120 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -2.961 6.777 -30,41 89,09 -263.795 603.763
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -51.219 9.738 -84,02 88,34 -4.524.686 860.255
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 20.000 60.957 48,83 59,31 1.186.200 3.615.360
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 10.000 40.957 32,30 46,09 460.900 1.887.708
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 9.360 30.957 43,34 12,67 118.591 392.225
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 3.120 21.597 16,89 4,42 13.790 95.459
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 18.477 14,50 8,78 20.545 162.228
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 10.840.560 0,02 8,78 20.545 95.180.117
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 18.477 14,50 8,78 20.545 162.228
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 11.457 25,67 4,04 9.454 46.286
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 9.117 34,53 0,90 2.106 8.205
2017-04-03 2017-04-03 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -61.420 3.584.087 -1,68 83,13 -5.105.845 297.945.152
2017-04-03 2017-03-31 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -23.689 3.645.507 -0,65 83,02 -1.966.661 302.649.991
2017-04-03 2017-03-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -6.223 3.669.196 -0,17 83,00 -516.509 304.543.268
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.600 23.274 -6,43 83,01 -132.816 1.931.975
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -500 6.777 -6,87 83,01 -41.505 562.559
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -58.755 3.675.419 -1,57 83,01 -4.877.253 305.096.531
2017-03-29 2017-03-28 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -6.182 3.734.174 -0,17 83,02 -513.230 310.011.125
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.300 24.874 -4,97 83,00 -107.900 2.064.542
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -400 7.277 -5,21 83,00 -33.200 603.991
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -37.731 3.740.356 -1,00 83,00 -3.131.673 310.449.548
2017-03-23 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -700 3.778.087 -0,02 83,01 -58.107 313.619.002
2017-03-23 2017-03-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -500 3.778.787 -0,01 83,10 -41.550 314.017.200
2017-03-20 2017-03-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -51.883 3.779.287 -1,35 82,10 -4.259.594 310.279.463
2017-03-20 2017-03-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -38.997 3.831.170 -1,01 82,01 -3.198.144 314.194.252
2017-03-20 2017-03-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.120 3.870.167 -0,24 82,08 -748.570 317.663.307
2017-01-06 2017-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -65.114 3.879.287 -1,65 85,16 -5.545.108 330.360.081
2016-11-14 2016-11-11 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -15.551 3.944.401 -0,39 85,00 -1.321.835 335.274.085
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.300 26.174 -4,73 85,00 -110.500 2.224.790
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -300 7.677 -3,76 85,00 -25.500 652.545
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.700 3.959.952 -0,04 87,05 -147.985 344.713.822
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -100 3.961.652 0,00 86,06 -8.606 340.939.771
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -167 3.961.752 0,00 86,00 -14.362 340.710.672
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -15.368 3.961.919 -0,39 85,10 -1.307.817 337.159.307
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -102.919 3.977.287 -2,52 80,09 -8.242.783 318.540.916
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -19.581 4.080.206 -0,48 79,24 -1.551.598 323.315.523
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -4.200 4.099.787 -0,10 78,23 -328.566 320.726.337
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.030 4.103.987 -0,22 77,13 -696.484 316.540.517
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.690 4.113.017 -0,28 76,49 -894.168 314.604.670
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.380 4.124.707 -0,03 75,70 -104.466 312.240.320
2016-11-09 2016-11-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -5.030 4.126.087 -0,12 75,39 -379.212 311.065.699
2016-11-04 2016-11-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -46.170 4.181.446 -1,09 75,00 -3.462.750 313.608.450
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -2.100 27.474 -7,10 70,00 -147.000 1.923.180
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -800 7.977 -9,11 70,00 -56.000 558.390
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -50.329 4.177.287 -1,19 70,41 -3.543.665 294.122.778
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -146.371 4.227.616 -3,35 70,00 -10.245.970 295.933.120
2016-10-04 2016-09-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -22.100 4.373.987 -0,50 70,06 -1.548.326 306.441.529
2016-09-30 2016-09-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -77.900 4.396.087 -1,74 70,04 -5.456.116 307.901.933
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -654 29.574 -2,16 66,17 -43.275 1.956.912
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -194 8.777 -2,16 66,17 -12.837 580.774
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.798 4.473.987 -0,04 67,24 -120.898 300.830.886
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -97.149 4.475.785 -2,12 66,15 -6.426.406 296.073.178
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -224 30.228 -0,74 62,33 -13.962 1.884.111
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -66 8.971 -0,73 62,33 -4.114 559.162
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -33.796 4.572.934 -0,73 62,33 -2.106.505 285.030.976
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -75 30.452 -0,25 62,26 -4.670 1.895.942
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -22 9.037 -0,24 62,26 -1.370 562.644
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.345 4.606.730 -0,25 62,26 -706.340 286.815.010
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -166 30.527 -0,54 62,83 -10.430 1.918.011
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -49 9.059 -0,54 62,83 -3.079 569.177
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -12.224 4.618.075 -0,26 63,25 -773.168 292.093.244
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -12.958 4.630.299 -0,28 62,45 -809.227 289.162.173
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -76 30.693 -0,25 62,78 -4.771 1.926.907
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -23 9.108 -0,25 62,78 -1.444 571.800
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.506 4.643.257 -0,25 62,78 -722.347 291.503.674
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -113 30.769 -0,37 63,12 -7.133 1.942.139
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -34 9.131 -0,37 63,12 -2.146 576.349
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -17.118 4.654.763 -0,37 63,14 -1.080.831 293.901.736
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -96 30.882 -0,31 61,00 -5.856 1.883.802
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -29 5.387 -0,54 61,00 -1.769 328.607
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.848 4.671.779 -0,21 61,19 -602.599 285.866.157
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -4.723 4.681.627 -0,10 60,85 -287.395 284.877.003
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -394 30.978 -1,26 60,78 -23.947 1.882.843
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -117 5.416 -2,11 60,78 -7.111 329.184
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -31.599 4.686.350 -0,67 62,21 -1.965.774 291.537.834
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.770 4.717.949 -0,25 61,65 -725.620 290.861.556
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -16.270 4.729.719 -0,34 60,66 -986.938 286.904.755
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -163 31.372 -0,52 60,70 -9.894 1.904.280
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -49 5.533 -0,88 60,70 -2.974 335.853
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -8.070 4.745.989 -0,17 61,31 -494.772 290.976.586
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
S - Sale -16.667 4.754.059 -0,35 60,51 -1.008.520 287.668.110
2016-06-30 2016-06-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
J - Other -9.903 5.582 -63,95
2016-05-24 2016-05-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
J - Other -9.360 9.360 -50,00
2016-05-24 2016-05-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -4.770.828 4.770.828 -50,00
2016-05-16 2016-05-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -13.980 41.081 -25,39 40,92 -572.062 1.681.035
2016-05-16 2016-05-12 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
S - Sale -4.000 55.061 -6,77 40,00 -160.000 2.202.440
2016-01-29 2016-01-27 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 393.700 5.062.363 8,43 6,35 2.499.995 32.146.005
2015-07-02 2015-07-01 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -2.970 59.061 -4,79
2015-05-13 2015-05-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -155.000 1.983.858 -7,25 21,50 -3.332.500 42.652.947
2015-05-13 2015-05-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -22.607 2.138.858 -1,05 22,26 -503.232 47.610.979
2015-05-07 2015-05-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -9.903 62.031 -13,77
2015-04-24 2015-04-24 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -25.000 2.161.465 -1,14 26,64 -666.000 57.581.428
2015-04-24 2015-04-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -22.643 2.186.465 -1,02 27,35 -619.286 59.799.818
2015-04-24 2015-04-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -10.000 2.209.108 -0,45 26,64 -266.400 58.850.637
2015-04-24 2015-04-22 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -25.249 2.219.108 -1,12 26,56 -670.613 58.939.508
2015-04-21 2015-04-21 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -14.167 2.244.357 -0,63 26,35 -373.300 59.138.807
2015-04-21 2015-04-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -12.792 2.258.524 -0,56 26,44 -338.220 59.715.375
2015-04-21 2015-04-17 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -18.861 2.271.316 -0,82 26,67 -503.023 60.575.998
2015-04-16 2015-04-16 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.290.177 0,00 26,75 -2.675 61.262.235
2015-04-16 2015-04-15 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.290.277 0,00 29,17 -2.917 66.807.380
2015-04-16 2015-04-15 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -39.900 2.290.377 -1,71 28,57 -1.139.943 65.436.071
2015-04-16 2015-04-14 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -13.814 2.330.277 -0,59 27,26 -376.570 63.523.351
2015-04-08 2015-04-07 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -3.600 2.344.091 -0,15 26,55 -95.580 62.235.616
2015-04-08 2015-04-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -3.895 2.347.691 -0,17 26,88 -104.698 63.105.934
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -8.035 2.351.586 -0,34 27,07 -217.507 63.657.433
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -39.819 2.359.621 -1,66 26,55 -1.057.194 62.647.938
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -14.600 2.399.440 -0,60 25,51 -372.446 61.209.714
2015-03-26 2015-03-25 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -4.956 2.414.040 -0,20 27,56 -136.587 66.530.942
2015-03-26 2015-03-24 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -13.200 2.418.996 -0,54 27,67 -365.244 66.933.619
2015-03-23 2015-03-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -5.000 2.432.196 -0,21 27,78 -138.900 67.566.405
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -84 2.437.196 0,00 28,15 -2.365 68.607.067
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -400 2.437.280 -0,02 28,13 -11.252 68.560.686
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -200 2.437.680 -0,01 28,04 -5.608 68.352.547
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -8.780 2.437.880 -0,36 27,19 -238.749 66.291.808
2015-03-23 2015-03-19 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -200 2.446.660 -0,01 28,07 -5.614 68.677.746
2015-03-23 2015-03-19 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -29.800 2.446.860 -1,20 27,55 -820.990 67.410.993
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.476.660 0,00 27,02 -2.702 66.919.353
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -500 2.476.760 -0,02 26,99 -13.495 66.847.752
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.477.260 0,00 27,04 -2.704 66.985.110
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -19.300 2.477.360 -0,77 26,56 -512.608 65.798.682
2015-03-18 2015-03-17 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -20.000 2.496.660 -0,79 25,94 -518.800 64.763.360
2015-03-18 2015-03-16 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -10.309 2.516.660 -0,41 25,43 -262.158 63.998.664
2015-03-12 2015-03-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -94.199 2.526.969 -3,59 24,94 -2.349.323 63.022.607
2015-03-12 2015-03-11 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -29.000 2.621.168 -1,09 25,02 -725.580 65.581.623
2015-03-12 2015-03-10 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -6.143 2.650.168 -0,23 24,65 -151.425 65.326.641
2015-03-09 2015-03-09 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -32.300 2.656.311 -1,20 25,61 -827.203 68.028.125
2015-03-09 2015-03-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.688.611 0,00 25,02 -2.502 67.269.047
2015-03-09 2015-03-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -1.046 2.688.711 -0,04 25,00 -26.150 67.217.775
2015-03-09 2015-03-05 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -6.000 2.689.757 -0,22 24,65 -147.900 66.302.510
2015-01-23 2015-01-23 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 811.966 4.668.663 21,05 5,85 4.750.001 27.311.679
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -305.810 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
X - Other 305.810 305.810
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock Warrant (right to buy)
X - Other -305.810 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -611.620 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series B Preferred Stock
C - Conversion -1.595.530 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 391.131 2.695.757 16,97 12,00 4.693.572 32.349.084
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -208.334 2.304.626 -8,29 12,00 -2.500.008 27.655.512
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 305.810 2.512.960 13,86
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 611.620 2.207.150 38,33
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 1.595.530 1.595.530
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series A-1 Preferred Stock
C - Conversion -117.441 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Convertible Subordinated Notes
C - Conversion
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy)
J - Other -141.825 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series C Preferred Stock
C - Conversion -328.821 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series B Preferred Stock
C - Conversion -1.393.000 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 1.120.833 3.856.697 40,97 6,00 6.724.998 23.140.182
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 158.174 2.735.864 6,14 6,00 949.044 16.415.184
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 460.350 2.577.690 21,74
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 1.950.200 2.117.340 1.166,81
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 164.417 167.140 6.038,08
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-04-17 2014-02-18 4/A EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 9.359 71.934 14,96
2014-04-17 2014-02-18 4/A EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 62.575 62.575
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Warrants
X - Other -1.614 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -9.359 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B-1 Convertible Preferred Stock
C - Conversion -62.575 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Warrants
X - Other -98.368 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -569.538 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B-1 Convertible Preferred Stock
C - Conversion -850.520 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1.028.613 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1.927.986 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
X - Other 357 72.291 0,50
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 9.359 72.291 14,87
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 62.575 71.934 668,61
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
P - Purchase 333.333 4.770.828 7,51 15,00 4.999.995 71.562.420
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
X - Other 21.837 4.437.495 0,49
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 569.538 4.415.658 14,81
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 850.520 3.846.120 28,39
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 1.028.616 2.995.600 52,29
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 1.927.986 1.966.987 4.943,43
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)